/
FDA Oncology Full Consolidated Comments
FDA Oncology Full Consolidated Comments
Overview |
This file contains the consolidated comments from the FDA Oncology Safety Data Standards Project Team. The goals of this phase of the project was to obtain broad industry and CRO feedback on version 1.3 of the OCE/OOD standard safety data request. The comments in the following tabs should not be considered as the consolidated opinion of the project team but the complete set of feedback collected from project team members for consideration to be included in a future version of the specifications. No indication is given to the status of the comments. |
, multiple selections available,
Related content
FDA Oncology Safety Data Standards
FDA Oncology Safety Data Standards
More like this
Safety Analytics
Safety Analytics
More like this
Optimizing the Use of Data Standards
Optimizing the Use of Data Standards
More like this
Nonclinical Study Data Reviewer's Guide
Nonclinical Study Data Reviewer's Guide
More like this
Recommendations for Adverse Event Collection and Treatment Emergent Definition
Recommendations for Adverse Event Collection and Treatment Emergent Definition
More like this